NGN Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 5

Professionals

  • Investments
  • 59

  • Portfolio
  • 1

  • Exits
  • 34

Exits

NGN Capital General Information

Company Description

Founded in 2003, NGN Capital is a venture capital firm based in Stamford, Connecticut. The firm prefers to invest in companies operating in the healthcare, biotechnology, drug products, medical devices, and healthcare services sectors across the United States and Europe. This firm is a Registered Investment Adviser (RIA).

Business Details

Year Founded
2003
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Corporate Office
  • 60 Long Ridge Road
  • Suite 402
  • Stamford, CT 06902
  • United States
+1 (212)

NGN Capital Investments (59)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cardiovalve 01-Aug-2020 Later Stage VC Therapeutic Devices Generating Revenue
OptiScan 20-Mar-2019 Monitoring Equipment Bankruptcy: Admin/Reorg
Exosome Diagnostics 05-Jul-2017 Laboratory Services (Healthcare) Generating Revenue
Exosome Diagnostics 07-Jan-2016 Laboratory Services (Healthcare) Generating Revenue
Zenith Epigenetics 23-Jul-2014 Biotechnology Generating Revenue
Exosome Diagnostics 12-Mar-2014 Laboratory Services (Healthcare) Generating Revenue
Lean Startup Machine 05-Mar-2014 Business/Productivity Software Out of Business
Endosense 05-Mar-2013 Surgical Devices Generating Revenue
Cerapedics 12-Dec-2012 Later Stage VC Surgical Devices Generating Revenue
PIN Pharma 01-Jan-2012 Early Stage VC Drug Discovery Generating Revenue
You’re viewing 10 of 59 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NGN Capital Exits (34)

Company Name Exit Date Exit Type Exit Size
Cardiovalve 25-Jan-2022 Merger/Acquisition
Lean Startup Machine 17-Dec-2021
Cerapedics 01-Aug-2021
PIN Pharma 01-Apr-2021
OptiScan 02-Jun-2020
Zenith Epigenetics 06-Mar-2020
Exosome Diagnostics 01-Aug-2018
Valtech Cardio 23-Jan-2017
BeneChill 01-Oct-2016 Merger/Acquisition
SpineView 01-Oct-2016 Out of Business
You’re viewing 10 of 34 exits. Get the full list »

NGN Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore NGN Capital‘s full profile, request access.

Request a free trial

NGN Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

NGN Capital FAQs

  • What is NGN Capital?

    Founded in 2003, NGN Capital is a venture capital firm based in Stamford, Connecticut.

  • When was NGN Capital founded?

    NGN Capital was founded in 2003.

  • Where is NGN Capital headquartered?

    NGN Capital is headquartered in Stamford, CT.

  • What is NGN Capital's total asset value?

    NGN Capital has around in total assets under management.

  • How many investments has NGN Capital made?

    NGN Capital has made 59 investments.

  • What has NGN Capital invested in?

    NGN Capital has made numerous investments in companies like Cardiovalve, OptiScan, and Exosome Diagnostics within the Therapeutic Devices, Monitoring Equipment, and Laboratory Services (Healthcare) industries.

  • What has NGN Capital invested in recently?

    NGN Capital's latest investment was on 01-Aug-2020 in Cardiovalve, a company within the Therapeutic Devices industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process